Trial intelligence / Profile preview

Varenicline in Friedreich's Ataxia

NCT00803868Phase 3Terminated

Sponsor
University of South Florida
Start
May 2009
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of varenicline in Friedreich's ataxia (FA), sponsored by University of South Florida. Started May 2009; status: terminated.

02

Drugs

varenicline
03

Conditions

Friedreich's ataxia (FA)

Beyond the preview

Go deeper on NCT00803868.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00803868.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call